First published online 18 February 2004
doi: 10.1242/dev.01007
Development 131, 1299-1308 (2004)
Published by The Company of Biologists 2004
Reiterated Wnt signaling during zebrafish neural crest development
Jessica L. Lewis1,
Jennifer Bonner2,
Melinda Modrell3,*,
Jared W. Ragland1,
Randall T. Moon1,4,5,
Richard I. Dorsky2 and
David W. Raible1,3,5,
1 Molecular and Cellular Biology Program, University of Washington School of
Medicine, Seattle, WA 98195, USA
2 Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT
84132, USA
3 Department of Biological Structure, University of Washington School of
Medicine, Seattle, WA 98195, USA
4 Howard Hughes Medical Institute and Department of Pharmacology, University of
Washington School of Medicine, Seattle, WA 98195, USA
5 Center for Developmental Biology, University of Washington School of Medicine,
Seattle, WA 98195, USA

View larger version (87K):
[in a new window]
|
Fig. 2. Temporal limit for the Wnt/ß-catenin signaling requirement.
Foxd3-positive neural crest cells, identified by anti-Foxd3 primary antibody
(red), flank the neural plate after heat activation at bud (A), 3-somite (B),
and 6-somite stages (C). Transgenic embryos show significant loss of Foxd3
expression upon heat activation of hs- Tcf (green) (D,E), while Foxd3
expression is comparable to that of wild-type siblings after induction at
6-somites (F). All images are dorsal views, anterior to top, of stacked 10X
confocal series after fixation at 3-somites (A,D) or 10-somites (B,C,E,F).
Expression of the transgene is shown in the insets (D,E,F).
|
|

View larger version (72K):
[in a new window]
|
Fig. 3. Loss of canonical Wnt signaling does not alter Hu expression. (A,B)
Foxd3-positive neural crest cells (outline empty arrowhead), identified by
anti-Foxd3 primary antibody (red), flank the neural plate after heat
activation at the 3-somite stage. As shown in (B), transgenic embryos show
significant loss of Foxd3 expression upon heat activation of hs- Tcf
(green) as compared to with wild-type siblings (A). (C,D,E) Anti-Hu antibody,
which recognizes the pan-neuronal marker Hu, was were used to identify
Hu-positive cells in heat-activation treated embryos (red). Normal expression
is detected in the trigeminal ganglia (white arrowhead), Rohon-Beard sensory
neurons (white arrow), and primary motorneurons in the spinal column
(asterisk) in Tcf embryos (D) as compared to with their wild-type
siblings (C). Overlap between Hu and transgene expression is seen at higher
power (E). All images are dorsal views of flat-mounted embryos fixed at the
10-somite stage, anterior to top, of stacked confocal series obtained at 10X
(A-D) or 20X (E).
|
|

View larger version (101K):
[in a new window]
|
Fig. 4. Canonical Wnt/ß-catenin signaling is required in neural crest
precursors cell-autonomously. (A) As a control, rhodamine dextran-labeled
wild-type neural crest precursors (red) were transplanted into a wild-type
host embryo. The transplanted cells express Foxd3, detected with anti-Foxd3
antibody (green) when transplanted into a wild-type host embryo. Inset is a
single confocal slice to indicate co-localization in single transplanted cell
(white arrowhead). (B,C) Transgenic crest precursors fail to express Foxd3
when transplanted into a wild-type environment. Embryo shown is a dorsal view
with anterior to the top. Inset in (B) is magnified in (C). (D-F) Wild-type
cells express Foxd3 when transplanted into a transgenic environment. (D)
Foxd3-positive nuclei, detected with anti-Foxd3 primary antibody (red), are
observed in transplanted cells from wild-type donor embryos. (E) GFP-positive
nuclei (green) are observed in the Tcf background after heat-activation
of the transgene. (F) Stacked confocal images have been merged to show of
failure of Foxd3-positive nuclei to co-localize with background GFP
expression.
|
|

View larger version (26K):
[in a new window]
|
Fig. 5. Wnt8 and pax3 show overlapping expression in the
presumptive neural crest domain. (A) Whole-mount in-situ hybridization at the
80% epiboly stage reveals expression of wnt8 transcripts at the
margin and along the dorsal side of the embryo. (B) Expression of
pax3 in the presumptive neural crest (arrow). (C) The wnt8
expression domain is in proximity to, and partially overlapping with,
expression of pax3 in the presumptive neural crest region (black
arrow). All images are lateral views, with dorsal to the right, of 80% epiboly
stage embryos after hybridization.
|
|

View larger version (100K):
[in a new window]
|
Fig. 6. Wnt8 is required for neural crest induction in vivo. Whole-mount in-situ
hybridization at the 6-somite stage reveals loss of early neural crest markers
foxd3 (A-C), pax3 (D-F), and sox10 (G-I) upon
injection of 20 mg/ml wnt8.1 Morpholino oligonucleotides (B,E,H). Such loss
was not detected upon injection of 20 mg/ml wnt8.2 Morpholino (C,F,I),
suggesting it does not have a role in neural crest induction. Uninjected
controls (A,D,G) show normal expression of markers in the neural crest;
foxd3 is also expressed in the notochord. All images are dorsal
views, anterior to top, of 3-somite embryos.
|
|

View larger version (80K):
[in a new window]
|
Fig. 7. Functional Wnt8 is not required for late expression of neural crest
markers. Whole-mount in-situ hybridization for neural crest marker,
sox10, on 10-somite (A,B) and 24hpf (C,D) stage embryos. (E,F)
Whole-mount in-situ hybridization for melanophore-specific marker,
mitfa. (G,H) Whole-mount in-situ hybridization for cranial neural
crest marker, dlx2. Injection of 20 mg/ml wnt8.1 antisense Morpholino
oligonucleotides does not significantly reduce or eliminate the expression of
any of these neural crest markers. All images of uninjected control siblings
(A,C,E,G) and wnt8.1 MO-injected embryos (B,D,F,H) are lateral views (B-F) or
dorsal views (A-B,G-H) with anterior to the left. Scale bar: 100 µm in
(A,B); 200 µm in (C-F); 50 µm in (G,H).
|
|

View larger version (89K):
[in a new window]
|
Fig. 8. Wnt/ß-catenin signaling is required for mitfa expression and
branchial arch expression of dlx2 upon crest migration. (A,B)
Whole-mount in-situ hybridization for melanophore-specific marker,
mitfa. (C,D) Whole-mount in-situ hybridization for neural crest
marker, sox10. (E-H) Whole-mount in-situ hybridization for cranial
neural crest marker, dlx2. Black arrowhead indicates few remaining
mitfa-expressing cells. Open arrowhead indicates normal pattern of
sox10-expressing neural crest. While telencephalon and diencephalon
expression is unchanged in TCF transgenic embryos, dlx2
expression is observed in the developing branchial arches. All images are
lateral views, anterior to the left, of wild-type siblings (A,C,E,G) and
hs Tcf-GFP transgenic embryos (D,E,F,H) after heat shock at the
18-somite stage and fixation at the 26-somite stage, except (G,H) which are
dorsal views of flat-mounted embryos, anterior to the left.
|
|
© The Company of Biologists Ltd 2004